Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis

Volume: 191, Pages: 216 - 221
Published: Jan 1, 2019
Abstract
Sepsis is a highly prevalent syndrome in the United States. The use of cell surface markers, as an effective tool to diagnosis sepsis, has been widely investigated. However, the study of the combination of multiple biomarkers to achieve higher diagnosis accuracy is rare. This study, the panel combined with CD25, CD64, and CD69 was constructed and better diagnosis ability was observed. Septic patients (n = 40), with the mean age of 61 ± 14, were...
Paper Details
Title
Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis
Published Date
Jan 1, 2019
Journal
Volume
191
Pages
216 - 221
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.